ATP6V1G1
- Aliases
-
- ATP6G
- ATP6G1
- ATP6GL
- ATP6J
- ATP6V1G1
- ATPase, H+ transporting, lysosomal (vacuolar proton pump), member J
- ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G isoform 1
- ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1
- DKFZp547P234
- V-ATPase 13 kDa subunit 1
- V-ATPase subunit G 1
- V-type proton ATPase subunit G 1
- Vacuolar proton pump subunit G 1
- Vacuolar proton pump subunit M16
- Vma10
- vacuolar ATP synthase subunit M16
- vacuolar H(+)-ATPase subunit G 1
- vacuolar proton pump subunit G 1
- vacuolar proton pump subunit M16
- Description
- ATP6V1G1 is a subunit of vacuolar ATPase (V-ATPase), a multisubunit enzyme. V-ATPase is an enzyme transporter that functions to acidify intracellular compartments in eukaryotic cells. This acidification process is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is ubiquitously expressed and is present in endomembrane organelles such as vacuoles, lysosomes, endosomes, the Golgi apparatus, chromaffin granules and coated vesicles, as well as in the plasma membrane. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A, three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site.
Attributes
- QA State
- Curated
- Type
- Protein
- HGNC Name
- ATP6V1G1
- Certifications
-
- None
- QA State for Breast
- Under Review
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
- Development and validation of sandwich ELISA microarrays with minimal assay interference.
- Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.
- Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.